Cardiovascular and cerebrovascular diseases (CVDs) remain an intractable problem and
have high morbidity and mortality worldwide, as well as substantial health and economic …

Ankylosing spondylitis (AS) is inflammatory arthritis predominantly affecting the spine, which
is involved in the disorders of both immune and skeletal systems. The exact pathogenesis of …

Although many therapeutic interventions have shown promise in treating spinal cord injury,
focusing on a single aspect of repair cannot achieve successful and functional regeneration …

Spinal cord injury (SCI) is a devastating medical condition with profound social and
economic impacts. Although research is ongoing, current treatment options are limited and …

Neurological disorders represent a global health problem. Current pharmacological
treatments often lead to short-term symptomatic relief but have dose-dependent side effects …

Multipotent mesenchymal stromal cells (MSCs) are a promising therapeutic tool for the
treatment of equine tendon and other musculoskeletal injuries. While bone marrow is …

The culture of multipotent mesenchymal stem cells on natural biopolymers holds great
promise for treatments of connective tissue disorders such as osteoarthritis. The safety and …

Cancer is a leading cause of death in both developed and develo** countries, and
because of population growth and aging, it is a growing medical burden worldwide. With …

Objective To study the osteogenic differentiation capacity of bone marrow–derived
mesenchymal stem cells (BM‐MSCs) from patients with ankylosing spondylitis (AS) and to …

Mesenchymal stromal/stem cells (MSCs) have been developed as a promising source for
cell-based therapies of ischemic disease. However, there are some hurdles in their clinical …